Back to MRKView full pipeline
Phase 2
Development Phase
0
Upcoming Catalysts
0
Historical Events
0
Regulatory Approvals
No Catalysts Found
No catalyst events have been recorded for this drug yet.
Competitive Landscape
0 competitors in Castration-resistant Prostate Cancer
View Full LandscapeDrug Information
Target Indication
Castration-resistant Prostate Cancer
Clinical Trial
NCT04090528Last updated: 8/27/2026
Patent & Exclusivity
No patent data available. Pre-approval drugs may not have Orange Book listings.
Drug Science
Mechanism of action & safety profile
Related Pipeline
9 valent human papillomavirus vaccine (Types 6, 11, 16, 18, 31, 33, 45, 52, 58)Phase 3
HPV Positive Oropharyngeal Squamous Cell Carcinoma
0.9% sodium chloride (NaCl)Phase 3
Anesthesia
sitagliptin/metforminPhase 3
Type 2 Diabetes Mellitus
Riociguat (Adempas, BAY63-2521)Phase 3
Hypertension, Pulmonary
losartan potassium (+) hydrochlorothiazidePhase 3
Hypertension
Get Catalyst Alerts
Receive weekly digests of upcoming catalysts